Atea Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.00
|
|
Average Rating
|
3.40
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.44
|
-0.10
|
0.34
|
77.27%
|
|
2022-06-30
|
-0.52
|
-0.38
|
0.14
|
26.92%
|
|
2022-03-31
|
-0.58
|
-0.51
|
0.07
|
12.07%
|
|
2021-12-31
|
0.17
|
1.34
|
1.17
|
688.24%
|
|
2021-09-30
|
-0.05
|
-0.34
|
-0.29
|
-580.00%
|
|
2021-06-30
|
0.01
|
0.02
|
0.01
|
100.00%
|
|
2021-03-31
|
-0.05
|
0.34
|
0.39
|
780.00%
|
|
2020-12-31
|
0.16
|
0.96
|
0.80
|
500.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.99
|
|
2021-12-31
|
1.36
|
|
2020-12-31
|
-0.99
|